The American Journal of Medicine
Volume 123, Issue 5 , Pages 439-445 , May 2010

Prevalence and Correlates of Skin Cancer Screening among Middle-aged and Older White Adults in the United States

This research was presented at the 2009 annual meeting of the Society of Behavioral Medicine, Montreal, Canada.

  • Elliot J. Coups, PhD

      Affiliations

    • The Cancer Institute of New Jersey and Department of Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick
    • Corresponding Author InformationRequests for reprints should be addressed to Elliot J. Coups, PhD, The Cancer Institute of New Jersey, 195 Little Albany Street, 5th floor, Room 5567, New Brunswick, NJ 08901
    • ,
  • Alan C. Geller, MPH, RN

      Affiliations

    • Division of Public Health Practice, Harvard School of Public Health, Boston, Mass
    • ,
  • Martin A. Weinstock, MD, PhD

      Affiliations

    • Dermatoepidemiology Unit, Veterans Affairs Medical Center, Providence, RI
    • Department of Dermatology, Rhode Island Hospital, Providence, RI
    • Departments of Dermatology and Community Health, Brown University, Providence, RI
    • ,
  • Carolyn J. Heckman, PhD

      Affiliations

    • Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pa
    • ,
  • Sharon L. Manne, PhD

      Affiliations

    • Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, Pa

References 

  1. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol. 2004;150:179–185
  2. American Cancer Society. Cancer Facts and Figures 2009. Atlanta, GA: American Cancer Society; 2009;
  3. Geller AC, Swetter SM, Brooks K, et al. Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J Am Acad Dermatol. 2007;57:555–572quiz 573-576
  4. Wartman D, Weinstock M. Are we overemphasizing sun avoidance in protection from melanoma?. Cancer Epidemiol Biomarkers Prev. 2008;17:469–470
  5. Margolis DJ, Halpern AC, Rebbeck T, et al. Validation of a melanoma prognostic model. Arch Dermatol. 1998;134:1597–1601
  6. Epstein DS, Lange JR, Gruber SB, et al. Is physician detection associated with thinner melanomas?. JAMA. 1999;281:640–643
  7. Schwartz JL, Wang TS, Hamilton TA, et al. Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer. 2002;95:1562–1568
  8. Chen SC, Pennie ML, Kolm P, et al. Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med. 2006;21:678–682
  9. Geller AC, O'Riordan DL, Oliveria SA, et al. Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. J Am Board Fam Pract. 2004;17:416–423
  10. Aitken JF, Elwood M, Baade PD, et al. Clinical whole-body skin examination reduces the incidence of thick melanomas. Int J Cancer. 2010;126(2):450–458
  11. U.S. Preventive Services Task Force. Screening for skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150:188–193
  12. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27–41
  13. Saraiya M, Hall HI, Thompson T, et al. Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med. 2004;39:308–314
  14. LeBlanc WG, Vidal L, Kirsner RS, et al. Reported skin cancer screening of US adult workers. J Am Acad Dermatol. 2008;59:55–63
  15. National Center for Health Statistics. NHIS Survey Description. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention; 2006;http://www.cdc.gov/nchs/nhis/quest_data_related_1997_forward.htmAccessed March 2, 2010
  16. Coups EJ, Manne SL, Meropol NJ, Weinberg DS. Multiple behavioral risk factors for colorectal cancer and colorectal cancer screening status. Cancer Epidemiol Biomarkers Prev. 2007;16:510–516
  17. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004;100:2093–2103
  18. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130–160
  19. Federman DG, Kravetz JD, Kirsner RS. Skin cancer screening by dermatologists: prevalence and barriers. J Am Acad Dermatol. 2002;46:710–714
  20. Kirsner RS, Muhkerjee S, Federman DG. Skin cancer screening in primary care: prevalence and barriers. J Am Acad Dermatol. 1999;41:564–566
  21. Rodriguez GL, Ma F, Federman DG, et al. Predictors of skin cancer screening practice and attitudes in primary care. J Am Acad Dermatol. 2007;57:775–781
  22. Reyes-Ortiz CA, Goodwin JS, Freeman JL, Kuo YF. Socioeconomic status and survival in older patients with melanoma. J Am Geriatr Soc. 2006;54:1758–1764
  23. Robinson JK, Mallett KA. The duty to inspect the skin and counsel those at risk to develop melanoma. JAMA. 2009;301:1702–1704
  24. Aitken JF, Youl PH, Janda M, et al. Validity of self-reported skin screening histories. Am J Epidemiol. 2004;159:1098–1105

 Funding: This research was supported by National Cancer Institute grants 5K07CA108685-04 (Heckman), 5K05CA109008-05 (Manne), and P30CA006927 (Fox Chase Cancer Center Core Grant).

 Conflict of Interest: None of the authors have any conflict of interest associated with this research.

 Authorship: All authors had access to the data and a role in writing the manuscript.

PII: S0002-9343(10)00015-X

doi: 10.1016/j.amjmed.2009.10.014

The American Journal of Medicine
Volume 123, Issue 5 , Pages 439-445 , May 2010

Article Tools